Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 142

1.

Bridging the gap in genetics: a progressive model for primary to specialist care.

Harding B, Webber C, Rühland L, Dalgarno N, Armour C, Birtwhistle R, Brown G, Carroll JC, Flavin M, Phillips SP, MacKenzie JJ.

BMC Med Educ. 2019 Jun 11;19(1):195. doi: 10.1186/s12909-019-1622-y.

2.

Implementation of comprehensive medication management at supermarket pharmacies in a pharmacy network.

Doong K, Berenbrok LA, Coley KC, Carroll JC, Richardson R, Antinopoulos BC, Patel A, McGivney MS.

J Am Pharm Assoc (2003). 2019 May 9. pii: S1544-3191(19)30143-8. doi: 10.1016/j.japh.2019.04.006. [Epub ahead of print]

PMID:
31080149
3.

Development of patient "profiles" to tailor counseling for incidental genomic sequencing results.

Mighton C, Carlsson L, Clausen M, Casalino S, Shickh S, McCuaig L, Joshi E, Panchal S, Graham T, Aronson M, Piccinin C, Winter-Paquette L, Semotiuk K, Lorentz J, Mancuso T, Ott K, Silberman Y, Elser C, Eisen A, Kim RH, Lerner-Ellis J, Carroll JC, Glogowski E, Schrader K, Bombard Y; Incidental Genomics Study Team.

Eur J Hum Genet. 2019 Mar 8. doi: 10.1038/s41431-019-0352-2. [Epub ahead of print]

PMID:
30846854
4.

Using prescription dispensing data infographics to facilitate collaborative pharmacist-prescriber discussions on mutual patients.

Carroll JC, Renner HM, McGivney MS, Grapsy J, McCormick K, Cooney SS, Coley KC.

J Am Pharm Assoc (2003). 2019 Mar - Apr;59(2):232-237.e1. doi: 10.1016/j.japh.2018.11.014. Epub 2019 Jan 9.

PMID:
30638731
5.

A framework to build capacity for a reflex-testing program for Lynch syndrome.

Palter VN, Baker NA, Rabeneck L, Tinmouth J, Gagliardi AR, Kennedy ED, Carroll JC, Gallinger S, Baxter NN.

Genet Med. 2019 Jun;21(6):1381-1389. doi: 10.1038/s41436-018-0342-8. Epub 2018 Oct 22.

PMID:
30349099
6.

Mendelian Randomization and mediation analysis of leukocyte telomere length and risk of lung and head and neck cancers.

Kachuri L, Saarela O, Bojesen SE, Davey Smith G, Liu G, Landi MT, Caporaso NE, Christiani DC, Johansson M, Panico S, Overvad K, Trichopoulou A, Vineis P, Scelo G, Zaridze D, Wu X, Albanes D, Diergaarde B, Lagiou P, Macfarlane GJ, Aldrich MC, Tardón A, Rennert G, Olshan AF, Weissler MC, Chen C, Goodman GE, Doherty JA, Ness AR, Bickeböller H, Wichmann HE, Risch A, Field JK, Teare MD, Kiemeney LA, van der Heijden EHFM, Carroll JC, Haugen A, Zienolddiny S, Skaug V, Wünsch-Filho V, Tajara EH, Ayoub Moysés R, Daumas Nunes F, Lam S, Eluf-Neto J, Lacko M, Peters WHM, Le Marchand L, Duell EJ, Andrew AS, Franceschi S, Schabath MB, Manjer J, Arnold S, Lazarus P, Mukeriya A, Swiatkowska B, Janout V, Holcatova I, Stojsic J, Mates D, Lissowska J, Boccia S, Lesseur C, Zong X, McKay JD, Brennan P, Amos CI, Hung RJ.

Int J Epidemiol. 2018 Jul 28. doi: 10.1093/ije/dyy140. [Epub ahead of print]

PMID:
30059977
7.

Primary care providers' lived experiences of genetics in practice.

Harding B, Webber C, Ruhland L, Dalgarno N, Armour CM, Birtwhistle R, Brown G, Carroll JC, Flavin M, Phillips S, MacKenzie JJ.

J Community Genet. 2019 Jan;10(1):85-93. doi: 10.1007/s12687-018-0364-6. Epub 2018 Apr 26.

8.

Evaluation of a decision aid for incidental genomic results, the Genomics ADvISER: protocol for a mixed methods randomised controlled trial.

Shickh S, Clausen M, Mighton C, Casalino S, Joshi E, Glogowski E, Schrader KA, Scheer A, Elser C, Panchal S, Eisen A, Graham T, Aronson M, Semotiuk KM, Winter-Paquette L, Evans M, Lerner-Ellis J, Carroll JC, Hamilton JG, Offit K, Robson M, Thorpe KE, Laupacis A, Bombard Y.

BMJ Open. 2018 Apr 26;8(4):e021876. doi: 10.1136/bmjopen-2018-021876.

9.

Genetic assessment wait time indicators in the High Risk Ontario Breast Screening Program.

Eisen A, Blackmore KM, Meschino WS, Muradali D, Carroll JC, Majpruz V, Warner E, Rabeneck L, Chiarelli AM.

Mol Genet Genomic Med. 2018 Mar;6(2):213-223. doi: 10.1002/mgg3.359. Epub 2018 Jan 25.

10.

False-Positive Newborn Screening for Cystic Fibrosis and Health Care Use.

Hayeems RZ, Miller FA, Vermeulen M, Potter BK, Chakraborty P, Davies C, Carroll JC, Ratjen F, Guttmann A.

Pediatrics. 2017 Nov;140(5). pii: e20170604. doi: 10.1542/peds.2017-0604. Epub 2017 Oct 12.

11.

Teaching Primary Care Genetics: A Randomized Controlled Trial Comparison.

Telner D, Carroll JC, Regehr G, Tabak D, Semotiuk K, Freeman R.

Fam Med. 2017 Jun;49(6):443-450.

12.

Multigene expression profile testing in breast cancer: is there a role for family physicians?

O'Brien MA, Carroll JC, Manca DP, Miedema B, Groome PA, Makuwaza T, Easley J, Sopcak N, Jiang L, Decker K, McBride ML, Moineddin R, Permaul JA, Heisey R, Eisenhauer EA, Krzyzanowska MK, Pruthi S, Sawka C, Schneider N, Sussman J, Urquhart R, Versaevel C, Grunfeld E; Canadian Team to Improve Community-Based Cancer Care Along the Continuum.

Curr Oncol. 2017 Apr;24(2):95-102. doi: 10.3747/co.24.3457. Epub 2017 Apr 27.

13.

Psychosocial Response to Uncertain Newborn Screening Results for Cystic Fibrosis.

Hayeems RZ, Miller FA, Barg CJ, Bombard Y, Carroll JC, Tam K, Kerr E, Chakraborty P, Potter BK, Patton S, Bytautas JP, Taylor L, Davies C, Milburn J, Price A, Gonska T, Keenan K, Ratjen F, Guttmann A.

J Pediatr. 2017 May;184:165-171.e1. doi: 10.1016/j.jpeds.2017.01.049. Epub 2017 Mar 6.

PMID:
28279431
14.

Assessing family history of chronic disease in primary care: Prevalence, documentation, and appropriate screening.

Carroll JC, Campbell-Scherer D, Permaul JA, Myers J, Manca DP, Meaney C, Moineddin R, Grunfeld E.

Can Fam Physician. 2017 Jan;63(1):e58-e67. Erratum in: Can Fam Physician. 2017 Oct;63(10 ):754-755.

15.

Primary care providers' experiences with and perceptions of personalized genomic medicine.

Carroll JC, Makuwaza T, Manca DP, Sopcak N, Permaul JA, O'Brien MA, Heisey R, Eisenhauer EA, Easley J, Krzyzanowska MK, Miedema B, Pruthi S, Sawka C, Schneider N, Sussman J, Urquhart R, Versaevel C, Grunfeld E.

Can Fam Physician. 2016 Oct;62(10):e626-e635.

16.

Coordination of cancer care between family physicians and cancer specialists: Importance of communication.

Easley J, Miedema B, Carroll JC, Manca DP, O'Brien MA, Webster F, Grunfeld E.

Can Fam Physician. 2016 Oct;62(10):e608-e615.

17.

Identification et prise en charge des femmes ayant des antécédents familiaux de cancer du sein: Guide pratique à l’intention des médecins.

Heisey R, Carroll JC.

Can Fam Physician. 2016 Oct;62(10):e572-e577. Review. French. No abstract available.

PMID:
27737991
Free PMC Article
18.

Patients' experiences with continuity of cancer care in Canada: Results from the CanIMPACT study.

Easley J, Miedema B, Carroll JC, O'Brien MA, Manca DP, Grunfeld E.

Can Fam Physician. 2016 Oct;62(10):821-827.

19.
20.

Universal tumor screening for Lynch syndrome: health-care providers' perspectives.

Bombard Y, Rozmovits L, Sorvari A, Daly C, Carroll JC, Kennedy E, Rabeneck L, Baxter NN.

Genet Med. 2017 May;19(5):568-574. doi: 10.1038/gim.2016.150. Epub 2016 Oct 6.

PMID:
27711070
21.

Opinion commune de la SOGC et du CCGM sur le dépistage génétique en contexte de procréation : Mise à jour à l'intention de l'ensemble des prestataires canadiens de soins de santé maternelle et de services en procréation, à l'ère des tests offerts directement aux consommateurs.

Wilson RD, De Bie I, Armour CM, Brown RN, Campagnolo C, Carroll JC, Okun N, Nelson T, Zwingerman R.

J Obstet Gynaecol Can. 2016 Aug;38(8):763-787.e4. doi: 10.1016/j.jogc.2016.07.008. No abstract available.

PMID:
27638988
22.

Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing.

Wilson RD, De Bie I, Armour CM, Brown RN, Campagnolo C, Carroll JC, Okun N, Nelson T, Zwingerman R, Audibert F, Brock JA, Brown RN, Campagnolo C, Carroll JC, De Bie I, Johnson JA, Okun N, Pastruck M, Vallée-Pouliot K, Wilson RD, Zwingerman R, Armour C, Chitayat D, De Bie I, Fernandez S, Kim R, Lavoie J, Leonard N, Nelson T, Taylor S, Van Allen M, Van Karnebeek C.

J Obstet Gynaecol Can. 2016 Aug;38(8):742-762.e3. doi: 10.1016/j.jogc.2016.06.008.

PMID:
27638987
23.

A secondary benefit: the reproductive impact of carrier results from newborn screening for cystic fibrosis.

Bombard Y, Miller FA, Barg CJ, Patton SJ, Carroll JC, Chakraborty P, Potter BK, Tam K, Taylor L, Kerr E, Davies C, Milburn J, Ratjen F, Guttmann A, Hayeems RZ.

Genet Med. 2017 Apr;19(4):403-411. doi: 10.1038/gim.2016.125. Epub 2016 Sep 8.

24.

The Gene Messenger Impact Project: An Innovative Genetics Continuing Education Strategy for Primary Care Providers.

Carroll JC, Grad R, Allanson JE, Pluye P, Permaul JA, Pimlott N, Wilson BJ.

J Contin Educ Health Prof. 2016 Summer;36(3):178-85. doi: 10.1097/CEH.0000000000000079.

PMID:
27583994
25.

Parent Experience With False-Positive Newborn Screening Results for Cystic Fibrosis.

Hayeems RZ, Miller FA, Barg CJ, Bombard Y, Kerr E, Tam K, Carroll JC, Potter BK, Chakraborty P, Davies C, Milburn J, Patton S, Bytautas JP, Taylor L, Price A, Gonska T, Keenan K, Ratjen F, Guttmann A.

Pediatrics. 2016 Sep;138(3). pii: e20161052. doi: 10.1542/peds.2016-1052. Epub 2016 Aug 2.

26.

NPT088 reduces both amyloid-β and tau pathologies in transgenic mice.

Levenson JM, Schroeter S, Carroll JC, Cullen V, Asp E, Proschitsky M, Chung CH, Gilead S, Nadeem M, Dodiya HB, Shoaga S, Mufson EJ, Tsubery H, Krishnan R, Wright J, Solomon B, Fisher R, Gannon KS.

Alzheimers Dement (N Y). 2016 Jul 14;2(3):141-155. doi: 10.1016/j.trci.2016.06.004. eCollection 2016 Sep.

27.

Academic family health teams: Part 2: patient perceptions of access.

Carroll JC, Talbot Y, Permaul J, Tobin A, Moineddin R, Blaine S, Bloom J, Butt D, Kay K, Telner D.

Can Fam Physician. 2016 Jan;62(1):e31-9.

28.

Academic family health teams: Part 1: patient perceptions of core primary care domains.

Carroll JC, Talbot Y, Permaul J, Tobin A, Moineddin R, Blaine S, Bloom J, Butt D, Kay K, Telner D.

Can Fam Physician. 2016 Jan;62(1):e23-30.

29.

Supporting genetics in primary care: investigating how theory can inform professional education.

Wilson BJ, Islam R, Francis JJ, Grimshaw JM, Permaul JA, Allanson JE, Blaine S, Graham ID, Meschino WS, Ramsay CR, Carroll JC.

Eur J Hum Genet. 2016 Nov;24(11):1541-1546. doi: 10.1038/ejhg.2016.68. Epub 2016 Jun 22.

30.

Using Newborn Screening Bloodspots for Research: Public Preferences for Policy Options.

Hayeems RZ, Miller FA, Barg CJ, Bombard Y, Cressman C, Painter-Main M, Wilson B, Little J, Allanson J, Avard D, Giguere Y, Chakraborty P, Carroll JC.

Pediatrics. 2016 Jun;137(6). pii: e20154143. doi: 10.1542/peds.2015-4143. Epub 2016 May 17.

31.

Attitudes to incorporating genomic risk assessments into population screening programs: the importance of purpose, context and deliberation.

Nicholls SG, Etchegary H, Carroll JC, Castle D, Lemyre L, Potter BK, Craigie S, Wilson BJ; CIHR Emerging Team in Genomics and Screening.

BMC Med Genomics. 2016 May 23;9(1):25. doi: 10.1186/s12920-016-0186-5.

32.

Developing clinical decision tools to implement chronic disease prevention and screening in primary care: the BETTER 2 program (building on existing tools to improve chronic disease prevention and screening in primary care).

Manca DP, Campbell-Scherer D, Aubrey-Bassler K, Kandola K, Aguilar C, Baxter J, Meaney C, Salvalaggio G, Carroll JC, Faria V, Nykiforuk C, Grunfeld E; original BETTER Trial Investigators and Clinical Working Group.

Implement Sci. 2015 Aug 4;10:107. doi: 10.1186/s13012-015-0299-9.

33.

Public Perceptions of the Benefits and Risks of Newborn Screening.

Miller FA, Hayeems RZ, Bombard Y, Cressman C, Barg CJ, Carroll JC, Wilson BJ, Little J, Allanson J, Chakraborty P, Giguère Y, Regier DA.

Pediatrics. 2015 Aug;136(2):e413-23. doi: 10.1542/peds.2015-0518. Epub 2015 Jul 13.

34.

Guideline harmonization and implementation plan for the BETTER trial: Building on Existing Tools to Improve Chronic Disease Prevention and Screening in Family Practice.

Campbell-Scherer D, Rogers J, Manca D, Lang-Robertson K, Bell S, Salvalaggio G, Greiver M, Korownyk C, Klein D, Carroll JC, Kahan M, Meuser J, Buchman S, Barrett RM, Grunfeld E.

CMAJ Open. 2014 Jan 22;2(1):E1-E10. doi: 10.9778/cmajo.20130040. eCollection 2014 Jan.

35.

Benefits and burdens of newborn screening: public understanding and decision-making.

Nicholls SG, Wilson BJ, Etchegary H, Brehaut JC, Potter BK, Hayeems R, Chakraborty P, Milburn J, Pullman D, Turner L, Carroll JC.

Per Med. 2014 Aug;11(6):593-607. doi: 10.2217/pme.14.46.

36.

Effectiveness of screening with annual magnetic resonance imaging and mammography: results of the initial screen from the ontario high risk breast screening program.

Chiarelli AM, Prummel MV, Muradali D, Majpruz V, Horgan M, Carroll JC, Eisen A, Meschino WS, Shumak RS, Warner E, Rabeneck L.

J Clin Oncol. 2014 Jul 20;32(21):2224-30. doi: 10.1200/JCO.2013.52.8331. Epub 2014 Jun 16.

PMID:
24934793
37.

Finding a BETTER way: a qualitative study exploring the prevention practitioner intervention to improve chronic disease prevention and screening in family practice.

Manca DP, Greiver M, Carroll JC, Salvalaggio G, Cave A, Rogers J, Pencharz J, Aguilar C, Barrett R, Bible S, Grunfeld E.

BMC Fam Pract. 2014 Apr 11;15:66. doi: 10.1186/1471-2296-15-66.

38.

Efficacy of an educational intervention on family physicians' risk assessment and management of colorectal cancer.

Carroll JC, Blaine S, Permaul J, Dicks E, Warner E, Esplen MJ, Rothenmund H, Semotiuk K, Worrall G, McLaughlin J.

J Community Genet. 2014 Oct;5(4):303-11. doi: 10.1007/s12687-014-0185-1. Epub 2014 Apr 9.

39.

Public views on participating in newborn screening using genome sequencing.

Bombard Y, Miller FA, Hayeems RZ, Barg C, Cressman C, Carroll JC, Wilson BJ, Little J, Avard D, Painter-Main M, Allanson J, Giguere Y, Chakraborty P.

Eur J Hum Genet. 2014 Nov;22(11):1248-54. doi: 10.1038/ejhg.2014.22. Epub 2014 Feb 19.

40.

Public attitudes towards genomic risk profiling as a component of routine population screening.

Nicholls SG, Wilson BJ, Craigie SM, Etchegary H, Castle D, Carroll JC, Potter BK, Lemyre L, Little J.

Genome. 2013 Oct;56(10):626-33. doi: 10.1139/gen-2013-0070. Epub 2013 Aug 31.

41.

Reflections on the cost of "low-cost" whole genome sequencing: framing the health policy debate.

Caulfield T, Evans J, McGuire A, McCabe C, Bubela T, Cook-Deegan R, Fishman J, Hogarth S, Miller FA, Ravitsky V, Biesecker B, Borry P, Cho MK, Carroll JC, Etchegary H, Joly Y, Kato K, Lee SS, Rothenberg K, Sankar P, Szego MJ, Ossorio P, Pullman D, Rousseau F, Ungar WJ, Wilson B.

PLoS Biol. 2013 Nov;11(11):e1001699. doi: 10.1371/journal.pbio.1001699. Epub 2013 Nov 5.

42.

Primary care role in expanded newborn screening: After the heel prick test.

Hayeems RZ, Miller FA, Carroll JC, Little J, Allanson J, Bytautas JP, Chakraborty P, Wilson BJ.

Can Fam Physician. 2013 Aug;59(8):861-8.

43.

Family history: impact on coronary heart disease risk assessment beyond guideline-defined factors.

Hasanaj Q, Wilson BJ, Little J, Montazeri Z, Carroll JC; CIHR Emerging Team in Genomics in Screening.

Public Health Genomics. 2013;16(5):208-14. doi: 10.1159/000353460. Epub 2013 Jul 25.

44.

Maternal age-based prenatal screening for chromosomal disorders: attitudes of women and health care providers toward changes.

Carroll JC, Rideout A, Wilson BJ, Allanson J, Blaine S, Esplen MJ, Farrell S, Graham GE, MacKenzie J, Meschino WS, Prakash P, Shuman C, Taylor S, Tobin S.

Can Fam Physician. 2013 Jan;59(1):e39-47.

45.

What does the feminization of family medicine mean?

Biringer A, Carroll JC.

CMAJ. 2012 Oct 16;184(15):1752. doi: 10.1503/cmaj.120771. Epub 2012 Sep 24. No abstract available.

46.

Applying the 2011 Canadian guidelines for breast cancer screening in practice.

Warner E, Heisey R, Carroll JC.

CMAJ. 2012 Nov 6;184(16):1803-7. doi: 10.1503/cmaj.120392. Epub 2012 Sep 10. Review. No abstract available.

47.

17β-estradiol and progesterone regulate expression of β-amyloid clearance factors in primary neuron cultures and female rat brain.

Jayaraman A, Carroll JC, Morgan TE, Lin S, Zhao L, Arimoto JM, Murphy MP, Beckett TL, Finch CE, Brinton RD, Pike CJ.

Endocrinology. 2012 Nov;153(11):5467-79. doi: 10.1210/en.2012-1464. Epub 2012 Sep 7.

48.

Selectively silencing GSK-3 isoforms reduces plaques and tangles in mouse models of Alzheimer's disease.

Hurtado DE, Molina-Porcel L, Carroll JC, Macdonald C, Aboagye AK, Trojanowski JQ, Lee VM.

J Neurosci. 2012 May 23;32(21):7392-402. doi: 10.1523/JNEUROSCI.0889-12.2012.

49.

Evaluation of the effects of testosterone and luteinizing hormone on regulation of β-amyloid in male 3xTg-AD mice.

Rosario ER, Carroll JC, Pike CJ.

Brain Res. 2012 Jul 23;1466:137-45. doi: 10.1016/j.brainres.2012.05.011. Epub 2012 May 14.

50.

Family history tools in primary care: does one size fit all?

Wilson BJ, Carroll JC, Allanson J, Little J, Etchegary H, Avard D, Potter BK, Castle D, Grimshaw JM, Chakraborty P.

Public Health Genomics. 2012;15(3-4):181-8. doi: 10.1159/000336431. Epub 2012 Apr 4. Review.

Supplemental Content

Loading ...
Support Center